Safety, Tolerability, Kinetics, and Repeatability of the Novel LPA1 PET Ligand 18F-BMS-986327
Diseases of the Lung | Diseases of the Respiratory Systems
What is the purpose of this trial?
A study to evaluate Safety,Tolerability, Kinetics, and Repeatability of the Novel Lysophosphatidic Acid Receptor 1 (LPA1) Positron Emission Tomography (PET) Ligand 18F-BMS-986327.
- Ages18 years and older
- Trial withBristol-Myers Squibb Research and Development
- Start Date10/01/2019
- End Date12/31/2020
- Last Updated07/15/2021
- Study HIC#2000026009